©2024 Stanford Medicine
Localized Therapeutics for the Treatment of Gastrointestinal Disorders
Not Recruiting
Trial ID: NCT02290665
Purpose
The purpose of this study is to determine the patient preference for a biocompatible
thermosensitive solution-gel versus water or saline (liquid) enema. The thermosensitive
solution-gel is comprised of poloxamer, an inactive compound that is designated as GRAS
(generally recognized as safe) by FDA. It could subsequently be used as a medium for drug
delivery. The poloxamer (gel) is administered to study participants in order to assess
preference and proximal distribution.
Official Title
Localized Therapeutics for the Treatment of Gastrointestinal Disorders
Eligibility
Inclusion Criteria:
- Generally healthy
- Age 18 to 70 years old
- Non-pregnant
Exclusion Criteria:
- GI complaints
- Pregnancy
- Patients with previous colonic surgery or current bowel injury or obstruction
- Allergies to contrast
Intervention(s):
other: Thermosensitive gel rectal formulation
other: Saline enema
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sidhartha Sinha, MD